Microwave-synthesized NiZrO@GNP and NiZrO3@MWCNT nanocomposites: enhanced antimicrobial efficacy against biofilms and Mycobacterium smegmatis.

Publication date: Feb 01, 2025

The persistent challenge posed by antibiotic-resistant bacteria and tuberculosis necessitates innovative approaches to antimicrobial treatment. This study explores the synthesis and characterization of NiZrO₃ nanoparticles integrated with graphene nanoplatelets (GNP) and multi-walled carbon nanotubes (MWCNT), using a microwave-assisted green synthesis route, employing fenugreek (Trigonella foenum-graecum) seed extract as a gelling agent. The synthesised nanocomposites were systematically analyzed using XRD, FT-IR, Raman spectroscopy, HR-SEM and HR TEM analysis to assess structural, optical, and morphological properties. The antimicrobial and antibiofilm efficacy was evaluated against drug-resistant strains, including Escherichia coli and Klebsiella pneumoniae, by well diffusion method and crystal violet-Microtitre plate (CV-MtP) method. Notably, the NiZrO₃@MWCNT composite exhibited a maximum antibacterial inhibition zone of 13 mm and showed superior biofilm inhibition of 92. 8% against K. pneumoniae at 500 ppm. In contrast, NiZrO₃@GNP demonstrated a biofilm inhibition of 97% at 500 ppm. Furthermore, the microplate Alamar Blue assay (MABA) was employed to determine the minimum inhibitory concentration (MIC) against Mycobacterium smegmatis (MTS) with NiZrO₃@MWCNT achieving 96% inhibition and at 500 ppm. These results confirm the enhanced antimicrobial efficacy of the carbon-integrated nanocomposites over pure NiZrO₃, which showed limited activity. This research underscores the promise of NiZrO₃-based nanocomposites as advanced antimicrobial agents, offering a novel strategy to combat the global health threat of antibiotic resistance. The online version contains supplementary material available at 10. 1007/s13205-024-04201-5.

Concepts Keywords
500ppm Anti-bacterial activity
Biotech Anti-biofilm activity
Gnp Drug-resistant pathogens
Microwave NiZrO3
Tuberculosis

Semantics

Type Source Name
disease IDO bacteria
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Activated charcoal
drug DRUGBANK Tretamine
drug DRUGBANK Gentian violet cation
disease IDO assay
drug DRUGBANK Methyl isocyanate
disease IDO antibiotic resistance
drug DRUGBANK Dihydrotachysterol

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *